Biomarin Pharmaceutical Inc
BMRNNasdaqCIK 1048477HealthcareFiscal year ends Dec 31
Reports and events: 320 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:22 ET | 8-K | 2.02 Results of operations | 0001048477-26-000019 |
| 2026-09-3020:15 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-26-063981 |
| 2026-09-1512:31 ET | 8-K | 8.01 Other events | 0001628280-26-061973 |
| 2026-09-1413:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-061717 |
| 2026-09-0113:23 ET | 8-K | 8.01 Other events | 0001193125-26-377696 |
| 2026-08-3110:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-375275 |
| 2026-08-1812:39 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-354780 |
| 2026-08-0620:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001048477-26-000016 |
| 2026-08-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-26-000015 |
| 2026-07-1320:06 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001048477-26-000011 |
| 2026-06-0420:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-26-040812 |
| 2026-05-0517:59 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001048477-26-000008 |
| 2026-05-0420:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-26-000006 |
| 2026-04-2712:45 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-179243 |
| 2026-04-2320:20 ET | 8-K | 8.01 Other events | 0001193125-26-173770 |
| 2026-04-2120:19 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001628280-26-026290 |
| 2026-03-1612:30 ET | 8-K | 8.01 Other events | 0001193125-26-107314 |
| 2026-02-2617:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001048477-26-000004 |
| 2026-02-2321:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-26-000002 |
| 2026-02-1221:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-048736 |
| 2026-01-2921:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-029401 |
| 2026-01-2612:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-021718 |
| 2026-01-1221:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-010508 |
| 2025-12-2214:00 ET | 8-K | 8.01 Other events | 0001193125-25-327828 |
| 2025-12-1913:47 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-325856 |
| 2025-12-1721:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-322704 |
| 2025-10-2818:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001048477-25-000107 |
| 2025-10-2720:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000104 |
| 2025-10-0721:17 ET | 8-K | 2.02 Results of operations | 0001048477-25-000101 |
| 2025-08-1120:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001048477-25-000098 |
| 2025-08-0517:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001048477-25-000090 |
| 2025-08-0420:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000088 |
| 2025-08-0120:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001048477-25-000086 |
| 2025-05-2220:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-25-125040 |
| 2025-05-1611:54 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-121296 |
| 2025-05-0216:33 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001048477-25-000051 |
| 2025-05-0120:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000049 |
| 2025-04-0820:09 ET | DEF 14A | Proxy statementPeriod 2025-05-20 | 0001048477-25-000045 |
| 2025-03-0321:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-044103 |
| 2025-02-2421:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-033463 |
| 2025-02-2418:54 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001048477-25-000007 |
| 2025-02-1921:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-25-000004 |
| 2024-10-3119:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001048477-24-000152 |
| 2024-10-2920:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-24-000149 |
| 2024-09-2412:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-224139 |
| 2024-09-0416:52 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001048477-24-000136 |
| 2024-08-2821:02 ET | 8-K | 2.05 Exit or disposal costs | 0001048477-24-000132 |
| 2024-08-2221:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-205405 |
| 2024-08-0520:35 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001048477-24-000126 |
| 2024-08-0520:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001048477-24-000125 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. Listed shows no prices and gives no investment advice.